Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | THPO | P40225 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | SLC6A2 | P23975 | 11/20 | 0.45 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8860093 | 0.84 | SLC6A2 (0.48) | SLC6A2 | |
| SCHEMBL8873154 | 0.81 | ALDH1A1 (0.61) | CYP1A2CYP3A4CYP2C9ALDH1A1CYP2D6 | |
| SCHEMBL9850893 | 0.81 | SLC6A2 (0.44) | ALDH1A1SLC6A2 | |
| Water SCHEMBL9388278 | 0.80 | MAPK1 (0.61) | CYP1A2CYP3A4CYP2C9ALDH1A1CYP2D6 | |
| Water SCHEMBL9388270 | 0.80 | MAPK1 (0.61) | CYP1A2CYP3A4CYP2C9ALDH1A1CYP2D6 | |
| SCHEMBL8873100 | 0.80 | SLC6A2 (0.43) | ALDH1A1SLC6A2 | |
| SCHEMBL8874045 | 0.79 | ALDH1A1 (0.62) | CYP1A2CYP3A4CYP2C9ALDH1A1CYP2D6 | |
| SCHEMBL8872009 | 0.78 | SLC6A2 (0.42) | SLC6A2 | |
| SCHEMBL8295650 | 0.74 | ALDH1A1 (0.66) | CYP1A2CYP3A4CYP2C9ALDH1A1CYP2D6 | |
| Hydrochloric Acid SCHEMBL8300406 | 0.73 | MAPK1 (0.65) | CYP1A2CYP3A4CYP2C9ALDH1A1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5053511-A | Analgesics; anticonvulsants; treatment for alzheimers disease | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-10-01 | — | — | US | claimed |
| US-5686626-A | COGNITION ACTIVATORS | HOECHST MARION ROUSSEL, INC. (US) | 1997-11-11 | — | — | US | disclosed |
| US-5621116-A | CHEMICAL INTERMEDIATES; MEMORY ENHANCERS FOR TREATMENT OF ALZHEIMER*S, ANALGESICS, ANTICONVULSANTS | HOECHST MARION ROUSSEL, INC. (US) | 1997-04-15 | — | — | US | disclosed |
| US-5464846-A | Learning enhancement, Alzheimer's disease | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1995-11-07 | — | — | US | disclosed |
| EP-0415102-B1 | 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-ones, a process for their preparation and their use as medicaments | HOECHST ROUSSEL PHARMA (US) | 1995-02-01 | — | — | EP | disclosed |
| US-5179119-A | Cognition activators; alzheimer*s disease | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1993-01-12 | — | — | US | disclosed |
| US-5053511-A | Analgesics; anticonvulsants; treatment for alzheimers disease | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-10-01 | — | — | US | disclosed |
| EP-0415102-A1 | 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-ones, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1991-03-06 | — | — | EP | disclosed |